BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19240212)

  • 1. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.
    San-Cristobal P; Pacheco-Alvarez D; Richardson C; Ring AM; Vazquez N; Rafiqi FH; Chari D; Kahle KT; Leng Q; Bobadilla NA; Hebert SC; Alessi DR; Lifton RP; Gamba G
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4384-9. PubMed ID: 19240212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process.
    Castañeda-Bueno M; Cervantes-Pérez LG; Vázquez N; Uribe N; Kantesaria S; Morla L; Bobadilla NA; Doucet A; Alessi DR; Gamba G
    Proc Natl Acad Sci U S A; 2012 May; 109(20):7929-34. PubMed ID: 22550170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Metabolic Acidosis Activates Renal Tubular Sodium Chloride Cotransporter through Angiotension II-dependent WNK4-SPAK Phosphorylation Pathway.
    Fang YW; Yang SS; Cheng CJ; Tseng MH; Hsu HM; Lin SH
    Sci Rep; 2016 Jan; 6():18360. PubMed ID: 26728390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of sodium-chloride cotransporter modulation by angiotensin II.
    Castañeda-Bueno M; Gamba G
    Curr Opin Nephrol Hypertens; 2012 Sep; 21(5):516-22. PubMed ID: 22820370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
    Yang CL; Angell J; Mitchell R; Ellison DH
    J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis.
    Ring AM; Leng Q; Rinehart J; Wilson FH; Kahle KT; Hebert SC; Lifton RP
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4025-9. PubMed ID: 17360471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
    Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
    Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
    Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
    Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone does not require angiotensin II to activate NCC through a WNK4-SPAK-dependent pathway.
    van der Lubbe N; Lim CH; Meima ME; van Veghel R; Rosenbaek LL; Mutig K; Danser AH; Fenton RA; Zietse R; Hoorn EJ
    Pflugers Arch; 2012 Jun; 463(6):853-63. PubMed ID: 22549242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute insulin stimulation induces phosphorylation of the Na-Cl cotransporter in cultured distal mpkDCT cells and mouse kidney.
    Sohara E; Rai T; Yang SS; Ohta A; Naito S; Chiga M; Nomura N; Lin SH; Vandewalle A; Ohta E; Sasaki S; Uchida S
    PLoS One; 2011; 6(8):e24277. PubMed ID: 21909387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine vasopressin regulates the renal Na
    Carbajal-Contreras H; Murillo-de-Ozores AR; Magaña-Avila G; Marquez-Salinas A; Bourqui L; Tellez-Sutterlin M; Bahena-Lopez JP; Cortes-Arroyo E; Behn-Eschenburg SG; Lopez-Saavedra A; Vazquez N; Ellison DH; Loffing J; Gamba G; Castañeda-Bueno M
    Am J Physiol Renal Physiol; 2024 Feb; 326(2):F285-F299. PubMed ID: 38096266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway.
    Bazúa-Valenti S; Rojas-Vega L; Castañeda-Bueno M; Barrera-Chimal J; Bautista R; Cervantes-Pérez LG; Vázquez N; Plata C; Murillo-de-Ozores AR; González-Mariscal L; Ellison DH; Riccardi D; Bobadilla NA; Gamba G
    J Am Soc Nephrol; 2018 Jul; 29(7):1838-1848. PubMed ID: 29848507
    [No Abstract]   [Full Text] [Related]  

  • 13. WNK3 and WNK4 amino-terminal domain defines their effect on the renal Na+-Cl- cotransporter.
    San-Cristobal P; Ponce-Coria J; Vázquez N; Bobadilla NA; Gamba G
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1199-206. PubMed ID: 18701621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin dephosphorylates Kelch-like 3, reversing phosphorylation by angiotensin II and regulating renal electrolyte handling.
    Ishizawa K; Wang Q; Li J; Yamazaki O; Tamura Y; Fujigaki Y; Uchida S; Lifton RP; Shibata S
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3155-3160. PubMed ID: 30718414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion.
    Kahle KT; Wilson FH; Leng Q; Lalioti MD; O'Connell AD; Dong K; Rapson AK; MacGregor GG; Giebisch G; Hebert SC; Lifton RP
    Nat Genet; 2003 Dec; 35(4):372-6. PubMed ID: 14608358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNK4 regulates activity of the epithelial Na+ channel in vitro and in vivo.
    Ring AM; Cheng SX; Leng Q; Kahle KT; Rinehart J; Lalioti MD; Volkman HM; Wilson FH; Hebert SC; Lifton RP
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4020-4. PubMed ID: 17360470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin II on kinase-mediated sodium and potassium transport in the distal nephron.
    van der Lubbe N; Zietse R; Hoorn EJ
    Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):120-6. PubMed ID: 23165113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNK3, a kinase related to genes mutated in hereditary hypertension with hyperkalaemia, regulates the K+ channel ROMK1 (Kir1.1).
    Leng Q; Kahle KT; Rinehart J; MacGregor GG; Wilson FH; Canessa CM; Lifton RP; Hebert SC
    J Physiol; 2006 Mar; 571(Pt 2):275-86. PubMed ID: 16357011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the with no lysine kinase-STE20-proline alanine-rich kinase pathway reduces the hypertension induced by angiotensin II.
    Cervantes-Perez LG; Castaneda-Bueno M; Jimenez JV; Vazquez N; Rojas-Vega L; Alessi DR; Bobadilla NA; Gamba G
    J Hypertens; 2018 Feb; 36(2):361-367. PubMed ID: 28877076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model.
    Yang SS; Morimoto T; Rai T; Chiga M; Sohara E; Ohno M; Uchida K; Lin SH; Moriguchi T; Shibuya H; Kondo Y; Sasaki S; Uchida S
    Cell Metab; 2007 May; 5(5):331-44. PubMed ID: 17488636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.